Forbion Growth Opportunities Fund III Cooperatief U.A.
SEC Form 4 insider trading activity
Forbion Growth Opportunities Fund III Cooperatief U.A. has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Forbion Growth Opportunities Fund III Cooperatief U.A. is listed as 10% Owner at Braveheart Bio, Inc. Inside the rolling window, Forbion Growth Opportunities Fund III Cooperatief U.A. reported 1 open-market purchase totaling $64.8M in BRVE and no open-market sales.
Companies traded
Other insiders at BRVE
Insider Buying
$64.8M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Forbion Growth Opportunities Fund III Cooperatief U.A. made?
Forbion Growth Opportunities Fund III Cooperatief U.A. has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Forbion Growth Opportunities Fund III Cooperatief U.A. trade?
Forbion Growth Opportunities Fund III Cooperatief U.A. has filed SEC Form 4 disclosures for 1 company, including BRVE.
When was Forbion Growth Opportunities Fund III Cooperatief U.A.'s most recent SEC Form 4 filing?
Forbion Growth Opportunities Fund III Cooperatief U.A.'s most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Forbion Growth Opportunities Fund III Cooperatief U.A.'s total buy and sell value in the current window?
Inside the rolling retention window, Forbion Growth Opportunities Fund III Cooperatief U.A. bought $64.8M and sold $0 based on SEC Form 4 filings.
What was Forbion Growth Opportunities Fund III Cooperatief U.A.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 3,600,000 BRVE shares on 2026-08-07, worth $64.8M, per SEC Form 4 filings.